Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

It wouldn't appear that IPIX is on Gilead's radar concerning Remdesivir and 'combo-therapy'...

https://www.fiercebiotech.com/biotech/can-a-plasma-based-treatment-boost-remdesivir-nih-starts-phase-3-trial-to-find-out?mkt_tok=eyJpIjoiTURNNE1UTmtZalF3TWpNeiIsInQiOiI3TVh1eFY5U0NcLytVcmNYQlNQb09hTWdEMmtXb2VCMldTV0llV1NLYnlOWGZKVlVTVWJxWktuUXI4UjlXRDZqbk1XRm42bk1JZTYxd1lcL1lWcnJKaGdvR3JmdDhvXC8wdFhcLzYyekQ4dERGWXQzQU42MkhVY20yd2prcWtvSFc3XC9TbGZ1UEFtMWJZTzRpdVhHRDlPMEJwQT09In0%3D&mrkid=74197490

When the first placebo-controlled data for Gilead’s remdesivir came out, analysts agreed it was no “silver bullet” for COVID-19. But it didn’t have to be, said Gilead CEO Daniel O’Day, who saw it as a steppingstone to other treatments and one that could even be combined to work better. Now, the National Institutes of Health (NIH) will test that theory as it kicks off a global study pairing the antiviral drug with plasma-based treatments.